When does 2 plus 2 equal 5? A review of antimicrobial synergy testing
- PMID: 24920779
- PMCID: PMC4313275
- DOI: 10.1128/JCM.01121-14
When does 2 plus 2 equal 5? A review of antimicrobial synergy testing
Abstract
In this age of emerging antibiotic resistance, limited therapeutic options exist for treating multidrug-resistant organisms. Combination therapy is commonly employed to manage these infections despite little laboratory guidance as to the efficacy of this approach. Synergy testing methods have been used to assess the interaction of antibiotic combinations in vitro. This review will discuss the four primary methods used to assess synergy, as well as the data that exist for testing of cystic fibrosis. In the final analysis, this review concludes that there is not enough evidence to endorse synergy testing for routine clinical use.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.
Figures
References
-
- CLSI. 2014. Performance standards for antimicrobial susceptibility testing; 24th informational supplement. CLSI document M100-S24 Clinical and Laboratory Standards Institute, Wayne, PA.
-
- Grasela TH, Jr, Welage LS, Walawander CA, Timm EG, Pelter MA, Poirier TI, Walters JK. 1990. A nationwide survey of antibiotic prescribing patterns and clinical outcomes in patients with bacterial pneumonia. DICP 24:1220–1225. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
